Clinical Trial Update: Low-Dose Nedaplatin (CDGP:Cis-Diammine-Glycolatoplatinum)/5-FU Combined With Radiation for Esophageal Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating low-dose nedaplatin with 5-FU and radiation for esophageal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Esophageal Cancer
• Squamous Cell Carcinoma

Drugs mentioned

• 5-Fluorouracil (5-FU)
• Nedaplatin (nedaplatin)

Snippet

Sponsor: Hamamatsu University | Conditions: Esophageal Cancer, Squamous Cell Carcinoma | Phase 2 | Status: COMPLETED